Form 8-K - Current report:
SEC Accession No. 0001104659-08-065028
Filing Date
2008-10-21
Accepted
2008-10-21 16:20:27
Documents
3
Period of Report
2008-10-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-26535_18k.htm 8-K 33155
2 EX-99.1 a08-26535_1ex99d1.htm EX-99.1 159110
3 GRAPHIC g265351mmi001.jpg GRAPHIC 1721
  Complete submission text file 0001104659-08-065028.txt   196533
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 081133593
SIC: 2834 Pharmaceutical Preparations